The FGFR2 Gene Scaphocephaly, Maxillary Retrusion, and Mental Retardation Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at identifying mutations in the FGFR2 gene. These mutations are known to be associated with a range of developmental and craniofacial disorders, including scaphocephaly (a form of craniosynostosis characterized by a long, narrow head), maxillary retrusion (where the upper jaw is set back relative to the lower jaw), and varying degrees of mental retardation.
The test, priced at 4400 AED, utilizes advanced genetic sequencing techniques to analyze the FGFR2 gene, seeking alterations that might indicate a predisposition to these conditions. It is particularly valuable for families with a history of these disorders, offering insights that can guide clinical management, inform therapeutic interventions, and aid in future family planning. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a crucial step towards personalized medicine, providing patients and their families with targeted information that can enhance care strategies and improve quality of life.
The MAGEL2 Gene Schaaf-Yang Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MAGEL2 gene, which are associated with Schaaf-Yang syndrome. This rare genetic disorder is characterized by a range of symptoms, including developmental delays, intellectual disability, muscle weakness, and distinctive facial features, among others. The test is crucial for confirming a diagnosis of Schaaf-Yang syndrome, enabling early intervention and tailored management plans for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect the specific genetic alterations linked to this condition. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect reliable, accurate results that are essential for understanding and addressing the unique needs of those with Schaaf-Yang syndrome.
The Chr. 22q13.3 Gene Phelan-McDermid Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the chromosome 22q13.3 region, which are associated with Phelan-McDermid Syndrome (PMS). This condition, also known as 22q13.3 deletion syndrome, is a rare genetic disorder characterized by intellectual disability, delayed speech development, and autism spectrum disorders, among other symptoms. The test aims to provide conclusive genetic evidence for the diagnosis of PMS, facilitating early intervention and personalized management strategies for affected individuals.
Priced at 4400 AED, the test is conducted through advanced genetic sequencing techniques to detect the presence of deletions or mutations in the specified chromosome region. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. Results from this test can offer crucial information for families, enabling access to support services and informing decisions about care and treatment options. Given the complexity and rarity of Phelan-McDermid Syndrome, this genetic test represents a critical step in understanding and managing the condition.
The NRXN1 Gene Pitt-Hopkins Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the NRXN1 gene, which are associated with Pitt-Hopkins Syndrome (PTHS). PTHS is a rare genetic condition characterized by developmental delay, intellectual disability, distinctive facial features, and possible breathing problems. The test is crucial for confirming a clinical diagnosis of PTHS, enabling early intervention and personalized care plans for affected individuals.
Conducted through a detailed analysis of the patient's genetic material, this test looks specifically for abnormalities within the NRXN1 gene that are linked to the syndrome. Given the complexity and precision involved in genetic testing, the NRXN1 Gene Pitt-Hopkins Syndrome Genetic Test is priced at 4400 AED. By choosing DNA Labs UAE for this testing, patients and their families can expect comprehensive support, from the initial consultation through to the interpretation of results and guidance on subsequent steps.
The TCF4 Gene Pitt-Hopkins Syndrome Genetic Test is a specialized diagnostic procedure designed to identify mutations in the TCF4 gene, which are known to cause Pitt-Hopkins Syndrome (PTHS). PTHS is a rare genetic condition characterized by developmental delay, intellectual disability, distinctive facial features, and possible breathing problems. The test is crucial for confirming the diagnosis of PTHS, enabling early intervention and management of symptoms.
Performed at DNA Labs UAE, this genetic test involves analyzing the patient's DNA sample, usually obtained through a blood draw, to look for specific mutations in the TCF4 gene. The presence of these mutations confirms the diagnosis of Pitt-Hopkins Syndrome. The test is recommended for individuals showing symptoms of PTHS or for families with a history of the syndrome.
The cost of the TCF4 Gene Pitt-Hopkins Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the testing procedure, analysis, and post-test counseling to discuss the results. Given the complexity and the specialized nature of the test, it is performed in a well-equipped laboratory setting by professionals skilled in genetic testing and analysis. The results from this test can provide valuable information for the clinical management of the patient, including tailored therapies and support services to improve quality of life.
The POU1F1 Gene Pituitary Hormone Deficiency Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the POU1F1 gene. These mutations are associated with Pituitary Hormone Deficiency Type 1, a rare genetic disorder that affects the pituitary gland's ability to produce key hormones, leading to various physiological and developmental issues. The test is crucial for early diagnosis and management of the condition, offering insights that can guide treatment and intervention strategies. The cost of the test is 4400 AED, reflecting the advanced genetic analysis involved. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant step forward in personalized medicine, providing patients and their families with critical health information.
The PROP1 Gene Pituitary Hormone Deficiency Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PROP1 gene. These mutations are known to cause Pituitary Hormone Deficiency Type 2, a condition that affects the production of several essential hormones in the body, leading to a variety of health issues such as growth deficiencies, thyroid problems, and delayed puberty. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic anomalies in the PROP1 gene, providing crucial information for accurate diagnosis and enabling targeted treatment strategies. This test is vital for individuals exhibiting symptoms related to hormone deficiencies or those with a family history of pituitary disorders, facilitating early intervention and management of the condition.
The COL2A1 Gene Platyspondylic Skeletal Dysplasia Torrance Type Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the COL2A1 gene, which are responsible for the rare genetic disorder known as Platyspondylic Skeletal Dysplasia, Torrance Type. This condition is characterized by significant skeletal abnormalities including platyspondyly (flattened vertebrae), short stature, and other bone growth anomalies. The test is crucial for early diagnosis, which can significantly impact the management and treatment strategies for affected individuals. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately detect the specific genetic alterations associated with this condition. Through DNA Labs UAE, patients and healthcare providers can access this important genetic testing service to better understand and manage this rare skeletal dysplasia.
The "STRADA Gene Polyhydramnios Megalencephaly and Symptomatic Epilepsy Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the STRADA gene. These mutations are associated with a rare condition characterized by polyhydramnios (excess amniotic fluid), megalencephaly (abnormally large brain), and symptomatic epilepsy. This condition falls under the spectrum of developmental and epileptic encephalopathies, which are severe brain disorders affecting neurological development and function.
The test is critical for early diagnosis and management of the condition, enabling healthcare providers to tailor treatments that can significantly improve the quality of life for affected individuals. The cost of the test is set at 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately. Conducted in the advanced facilities of DNA Labs UAE, this test represents a crucial step for families seeking answers to complex genetic conditions influencing neurological development and function.
The "TUBB2B Gene Polymicrogyria Asymmetric Genetic Test" is a specialized diagnostic tool designed to identify mutations in the TUBB2B gene, which are linked to the development of polymicrogyria, a neurological condition characterized by abnormal brain development. Polymicrogyria involves the brain having many small and irregular folds, often leading to developmental delays, seizures, and issues with speech and muscle control. The TUBB2B gene plays a crucial role in the formation of microtubules, essential components for cell structure and division, which are particularly important in brain development.
This genetic test is particularly focused on detecting asymmetrical manifestations of polymicrogyria, where the malformations are not evenly distributed across both hemispheres of the brain, potentially leading to a wide range of neurological symptoms. By analyzing a patient's DNA for specific mutations in the TUBB2B gene, healthcare providers can confirm a diagnosis, allowing for early intervention strategies and tailored management plans to be implemented.
The test is available at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the detailed insights it provides into the patient's genetic makeup. This test represents a critical step forward in the personalized treatment of neurological disorders, offering hope for affected individuals and their families through targeted therapy and support.
